Best TWAS P=2.1e-11 · Best GWAS P=5.04e-10 conditioned to 0.000342
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | FPGT | 0.35 | 0.50 | enet | 22 | 0.50 | 2.8e-70 | 5.9 | -5.7 | 1.0e-08 | -0.18 | 0.03 | 0.97 | FALSE |
2 | CommonMind | Brain Pre-frontal Cortex | LRRIQ3 | 0.23 | 0.33 | lasso | 2 | 0.32 | 7.5e-40 | 5.9 | -5.9 | 4.7e-09 | -0.17 | 0.03 | 0.97 | FALSE |
3 | GTEx | Adipose Subcutaneous | FPGT | 0.20 | 0.14 | lasso | 7 | 0.14 | 2.8e-11 | 5.8 | -5.3 | 1.5e-07 | -0.16 | 0.04 | 0.96 | FALSE |
4 | GTEx | Adipose Visceral Omentum | FPGT | 0.19 | 0.18 | enet | 14 | 0.17 | 2.3e-09 | 5.5 | -5.6 | 2.6e-08 | -0.14 | 0.04 | 0.96 | FALSE |
5 | GTEx | Artery Aorta | FPGT | 0.18 | 0.20 | lasso | 4 | 0.17 | 8.5e-10 | 5.8 | -6.0 | 2.6e-09 | -0.17 | 0.03 | 0.97 | FALSE |
6 | GTEx | Cells EBV-transformed lymphocytes | FPGT | 0.31 | 0.22 | lasso | 3 | 0.25 | 1.3e-08 | 5.8 | -6.1 | 8.6e-10 | -0.16 | 0.03 | 0.96 | FALSE |
7 | GTEx | Cells Transformed fibroblasts | FPGT | 0.19 | 0.06 | lasso | 6 | 0.13 | 9.6e-10 | 5.8 | -5.2 | 1.8e-07 | -0.12 | 0.03 | 0.97 | FALSE |
8 | GTEx | Colon Sigmoid | FPGT | 0.26 | 0.13 | enet | 29 | 0.15 | 4.6e-06 | 5.5 | -6.7 | 2.1e-11 | -0.17 | 0.05 | 0.94 | TRUE |
9 | GTEx | Esophagus Gastroesophageal Junction | FPGT | 0.19 | 0.18 | enet | 9 | 0.18 | 5.9e-07 | 5.5 | -5.7 | 1.0e-08 | -0.16 | 0.04 | 0.95 | FALSE |
10 | GTEx | Esophagus Mucosa | FPGT | 0.13 | 0.14 | lasso | 4 | 0.11 | 9.1e-08 | 5.8 | -5.7 | 1.1e-08 | -0.15 | 0.04 | 0.96 | FALSE |
11 | GTEx | Heart Atrial Appendage | FPGT | 0.10 | 0.09 | lasso | 13 | 0.08 | 1.5e-04 | 5.8 | -5.5 | 3.6e-08 | -0.14 | 0.05 | 0.91 | FALSE |
12 | GTEx | Lung | FPGT | 0.08 | 0.05 | enet | 12 | 0.04 | 9.1e-04 | 5.8 | -5.9 | 3.4e-09 | -0.16 | 0.04 | 0.95 | FALSE |
13 | GTEx | Skin Not Sun Exposed Suprapubic | FPGT | 0.10 | 0.07 | enet | 13 | 0.05 | 1.7e-03 | 5.8 | -6.0 | 2.2e-09 | -0.17 | 0.04 | 0.96 | FALSE |
14 | GTEx | Skin Sun Exposed Lower leg | FPGT | 0.08 | 0.02 | enet | 12 | 0.04 | 2.5e-04 | 5.8 | -5.3 | 1.2e-07 | -0.20 | 0.04 | 0.92 | FALSE |
15 | METSIM | Adipose | FPGT | 0.06 | 0.06 | lasso | 6 | 0.07 | 1.0e-10 | 5.9 | -5.4 | 7.4e-08 | -0.13 | 0.03 | 0.97 | FALSE |
16 | ROSMAP | Brain Pre-frontal Cortex | TNNI3K | 0.18 | 0.17 | enet | 24 | 0.19 | 1.0e-23 | -5.2 | -5.7 | 1.4e-08 | -0.20 | 0.47 | 0.53 | FALSE |
17 | ROSMAP | Brain Pre-frontal Cortex | LRRIQ3 | 0.22 | 0.29 | enet | 15 | 0.29 | 5.8e-37 | 5.8 | -5.6 | 2.2e-08 | -0.14 | 0.03 | 0.97 | FALSE |
18 | ROSMAP | Brain Pre-frontal Cortex | RP4-650F12.2 | 0.08 | 0.04 | lasso | 3 | 0.03 | 1.6e-04 | -5.3 | -5.5 | 3.1e-08 | -0.18 | 0.11 | 0.88 | FALSE |
19 | ROSMAP | Brain Pre-frontal Cortex | FPGT-TNNI3K | 0.09 | 0.05 | enet | 17 | 0.08 | 1.5e-10 | -5.3 | -5.4 | 5.2e-08 | -0.11 | 0.21 | 0.79 | FALSE |
20 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | LRRIQ3 | 0.23 | 0.28 | lasso | 5 | 0.28 | 1.1e-23 | 5.8 | -5.5 | 3.2e-08 | -0.14 | 0.01 | 0.99 | FALSE |
21 | The Cancer Genome Atlas | Breast Invasive Carcinoma | LRRIQ3 | 0.19 | 0.28 | lasso | 8 | 0.27 | 5.6e-56 | 5.8 | -5.8 | 6.1e-09 | -0.16 | 0.01 | 0.99 | FALSE |
22 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | LRRIQ3 | 0.28 | 0.29 | lasso | 8 | 0.28 | 2.2e-14 | 5.8 | -5.8 | 4.8e-09 | -0.16 | 0.01 | 0.99 | FALSE |
23 | The Cancer Genome Atlas | Colon Adenocarcinoma | LRRIQ3 | 0.24 | 0.36 | enet | 20 | 0.36 | 1.7e-21 | 5.8 | -5.9 | 3.8e-09 | -0.17 | 0.01 | 0.99 | FALSE |
24 | The Cancer Genome Atlas | Esophageal Carcinoma | LRRIQ3 | 0.22 | 0.16 | blup | 75 | 0.21 | 2.4e-07 | 5.8 | -5.5 | 4.0e-08 | -0.15 | 0.01 | 0.99 | FALSE |
25 | The Cancer Genome Atlas | Glioblastoma Multiforme | FPGT | 0.15 | 0.01 | lasso | 10 | 0.00 | 4.0e-01 | 5.8 | -6.1 | 1.1e-09 | -0.26 | 0.01 | 0.64 | FALSE |
26 | The Cancer Genome Atlas | Glioblastoma Multiforme | LRRIQ3 | 0.29 | 0.23 | enet | 21 | 0.14 | 4.1e-05 | 5.8 | -6.0 | 2.6e-09 | -0.19 | 0.01 | 0.99 | FALSE |
27 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | LRRIQ3 | 0.24 | 0.33 | lasso | 9 | 0.32 | 3.3e-37 | 5.9 | -5.9 | 4.4e-09 | -0.17 | 0.01 | 0.99 | FALSE |
28 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | LRRIQ3 | 0.24 | 0.30 | enet | 11 | 0.31 | 1.2e-35 | 5.9 | -5.8 | 6.0e-09 | -0.16 | 0.01 | 0.99 | FALSE |
29 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | LRRIQ3 | 0.40 | 0.37 | lasso | 9 | 0.38 | 5.7e-23 | 5.8 | -5.7 | 1.0e-08 | -0.17 | 0.01 | 0.99 | FALSE |
30 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | TNNI3K | 0.11 | 0.06 | blup | 159 | 0.07 | 4.8e-05 | 2.9 | -6.1 | 1.4e-09 | -0.59 | 0.04 | 0.75 | TRUE |
31 | The Cancer Genome Atlas | Brain Lower Grade Glioma | LRRIQ3 | 0.29 | 0.40 | lasso | 5 | 0.40 | 4.1e-48 | 5.9 | -5.9 | 4.3e-09 | -0.17 | 0.01 | 0.99 | FALSE |
32 | The Cancer Genome Atlas | Liver Hepatocellular Carcinoma | LRRIQ3 | 0.11 | 0.09 | blup | 75 | 0.10 | 2.3e-05 | 5.9 | -5.6 | 2.7e-08 | -0.16 | 0.01 | 0.99 | FALSE |
33 | The Cancer Genome Atlas | Lung Adenocarcinoma | LRRIQ3 | 0.13 | 0.20 | lasso | 8 | 0.20 | 4.3e-23 | 5.8 | -5.6 | 1.9e-08 | -0.15 | 0.01 | 0.99 | FALSE |
34 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | LRRIQ3 | 0.20 | 0.36 | enet | 15 | 0.35 | 1.9e-41 | 5.8 | -5.7 | 9.4e-09 | -0.16 | 0.01 | 0.99 | FALSE |
35 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | LRRIQ3 | 0.20 | 0.26 | lasso | 8 | 0.24 | 1.9e-16 | 5.8 | -5.9 | 4.5e-09 | -0.16 | 0.01 | 0.99 | FALSE |
36 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | FPGT | 0.20 | 0.25 | lasso | 5 | 0.26 | 1.5e-11 | 5.8 | -5.5 | 2.9e-08 | -0.12 | 0.01 | 0.99 | FALSE |
37 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | LRRIQ3 | 0.34 | 0.39 | enet | 32 | 0.39 | 1.1e-17 | 5.9 | -5.7 | 1.4e-08 | -0.15 | 0.01 | 0.99 | FALSE |
38 | The Cancer Genome Atlas | Prostate Adenocarcinoma | FPGT | 0.12 | 0.15 | enet | 10 | 0.15 | 2.6e-15 | 5.9 | -5.5 | 4.4e-08 | -0.16 | 0.01 | 0.99 | FALSE |
39 | The Cancer Genome Atlas | Prostate Adenocarcinoma | LRRIQ3 | 0.29 | 0.44 | enet | 15 | 0.43 | 1.9e-49 | 5.9 | -5.8 | 7.3e-09 | -0.16 | 0.01 | 0.99 | FALSE |
40 | The Cancer Genome Atlas | Rectum Adenocarcinoma | LRRIQ3 | 0.27 | 0.24 | blup | 75 | 0.22 | 8.5e-06 | 5.9 | -5.7 | 1.1e-08 | -0.15 | 0.01 | 0.98 | FALSE |
41 | The Cancer Genome Atlas | Soft Tissue Sarcoma | LRRIQ3 | 0.17 | 0.31 | lasso | 2 | 0.30 | 4.0e-18 | 5.9 | -6.0 | 2.5e-09 | -0.15 | 0.01 | 0.99 | FALSE |
42 | The Cancer Genome Atlas | Soft Tissue Sarcoma | TNNI3K | 0.15 | 0.08 | lasso | 3 | 0.07 | 5.0e-05 | -5.3 | -5.8 | 4.9e-09 | -0.22 | 0.16 | 0.80 | FALSE |
43 | The Cancer Genome Atlas | Stomach Adenocarcinoma | LRRIQ3 | 0.20 | 0.32 | enet | 19 | 0.31 | 1.4e-22 | 5.8 | -5.9 | 4.8e-09 | -0.16 | 0.01 | 0.99 | FALSE |
44 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | LRRIQ3 | 0.17 | 0.17 | enet | 8 | 0.16 | 2.6e-06 | 5.8 | -5.9 | 4.6e-09 | -0.17 | 0.01 | 0.98 | FALSE |
45 | The Cancer Genome Atlas | Thyroid Carcinoma | FPGT | 0.16 | 0.16 | lasso | 7 | 0.16 | 1.6e-15 | 5.9 | -5.5 | 4.1e-08 | -0.14 | 0.01 | 0.99 | FALSE |
46 | The Cancer Genome Atlas | Thyroid Carcinoma | LRRIQ3 | 0.26 | 0.43 | lasso | 4 | 0.42 | 4.2e-44 | 5.9 | -5.5 | 2.8e-08 | -0.14 | 0.01 | 0.99 | FALSE |